GLP-1 receptor agonists, commonly used in managing type 2 diabetes and obesity, have gained attention for their potential implications in colorectal cancer (CRC)
The Synergy Focus Area Both What it Addresses The Connection: For both parties, PT-141 acts as a bridge
Further large-scale, randomised controlled trials with longer follow-up are needed before these medications can be considered an evidence-based treatment option for alcohol use disorder
Subcutaneous injections often cause less pain and are preferred for long-term or self-administered treatment
Tirzepitide Much like semaglutide, tirzepatide is a once-weekly injectable medication that can produce significant effects on weight loss
Zhao, Y., Li, Y., Zhang, Y., Liu, F., Zhu, D., & Sun, Y